ERBB3 and cancer: We previously demonstrated that in cancer cells, 9F7-F11 blocks the PI3K/AKT pathway [2, 32, 33], induces HER3 downregulation and promotes cell apoptosis [2, 33], leading to in vivo tumor regression [2, 32].